Detalhe da pesquisa
1.
Effectiveness of mRNA COVID-19 Monovalent and Bivalent Vaccine Booster Doses Against Omicron Severe Outcomes Among Adults Aged ≥50 Years in Ontario, Canada: A Canadian Immunization Research Network Study.
J Infect Dis
; 229(2): 394-397, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37798119
2.
Indirect impact of childhood 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian older adults: a Canadian Immunization Research Network (CIRN) retrospective observational study.
Thorax
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38359926
3.
Effectiveness and Duration of Protection of a Fourth Dose of Coronavirus Disease 2019 Messenger RNA Vaccine Among Long-term Care Residents in Ontario, Canada.
J Infect Dis
; 227(8): 977-980, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36461711
4.
Protection conferred by COVID-19 vaccination, prior SARS-CoV-2 infection, or hybrid immunity against Omicron-associated severe outcomes among community-dwelling adults.
Clin Infect Dis
; 2023 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38001037
5.
Leukemia: What Primary Care Physicians Need to Know.
Am Fam Physician
; 107(4): 397-405, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37054416
6.
Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes.
JAMA
; 327(15): 1478-1487, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35323842
7.
Characteristics Associated With Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Ontario, Canada: A Cohort Study.
Clin Infect Dis
; 73(10): 1840-1848, 2021 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33751026
8.
Incidence of Hospitalizations and Emergency Department Visits for Herpes Zoster in Immunocompromised and Immunocompetent Adults in Ontario, Canada, 2002-2016.
Clin Infect Dis
; 71(1): 22-29, 2020 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31436814
10.
11.
Fatal respiratory diphtheria in a visitor to Canada.
CMAJ
; 193(1): E19-E22, 2021 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33397635
12.
Diphtérie respiratoire mortelle chez une personne en visite au Canada.
CMAJ
; 193(10): E355-E358, 2021 03 08.
Artigo
em Francês
| MEDLINE | ID: mdl-33685959
13.
Global travel patterns and risk of measles in Ontario and Quebec, Canada: 2007-2011.
BMC Infect Dis
; 15: 341, 2015 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-26282392
14.
Invasive Pneumococcal Disease Epidemiology and Serotype Replacement After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Ontario, Canada, 2007-2022.
Open Forum Infect Dis
; 11(6): ofae275, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38868312
15.
A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection.
Heliyon
; 10(5): e26551, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38439866
16.
Pharmacokinetics of mavacoxib in New Zealand White rabbits (Oryctolagus cuniculus).
Am J Vet Res
; 84(5)2023 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990439
17.
Methodological changes implemented over time to support accurate and timely COVID-19 vaccine coverage estimates: Ontario, Canada.
Vaccine
; 41(21): 3328-3336, 2023 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37087395
18.
Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada.
JAMA Pediatr
; 177(4): 410-418, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36848096
19.
COVID-19 Vaccine Effectiveness Against Omicron Infection and Hospitalization.
Pediatrics
; 151(4)2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36866446
20.
Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes.
Nat Commun
; 14(1): 1273, 2023 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882416